Search results
Shanghai boosts efforts to attract foreign investment
China Daily· 1 day agoAmid the turbulent China-US relations, Shanghai is determined to attract more foreign investment to the city and maintain sub-national exchanges. The Shanghai< ...
GDS Holdings: Q1 Earnings Snapshot - WTOP News
WTOP Washington· 4 days agoSHANGHAI (AP) — SHANGHAI (AP) — GDS Holdings Limited (GDS) on Wednesday reported a loss of $47.9 million in its first quarter. On a per-share basis, the ...
111: Q1 Earnings Snapshot
San Francisco Chronicle· 3 days agoSHANGHAI (AP) — SHANGHAI (AP) — 111 Inc. (YI) on Thursday reported a loss of $1.9...
Bilibili: Q1 Earnings Snapshot
Houston Chronicle· 3 days agoSHANGHAI (AP) — SHANGHAI (AP) — Bilibili Inc. (BILI) on Thursday reported a loss of...
Breakdancer, 40, on cusp of fulfilling Olympic dream
AFP via Yahoo Sports· 5 days agoAt age 40, Japanese competitive breakdancer Ayumi Fukushima has been busting moves for longer than some of her rivals have been alive.On the sidelines of...
Zhang Ziyi Returns to Cannes Film Festival for First Time in Five Years
Just Jared· 2 days agoThe 45-year-old Chinese actress attended the premiere of the film She’s Got No Name during the 2024...
Shanghai Disney Resort to adopt new 6-tier pricing
China Daily· 2 days agoOn Friday, Shanghai Disney Resort announced a new six-tier pricing structure for admission to Shanghai Disneyland effective from Nov 24, adding two additional ...
Nissan Formula E Team Set To Gift Rivals With Unique Gift At Shanghai E-Prix
Sports Illustrated· 2 days agoWith the inaugural Shanghai E-Prix this weekend, the Nissan Formula E Team is set to introduce a new...
Tesla unit seen lifting energy storage sector
China Daily· 1 day agoShanghai luminaries have expressed hopes that Tesla's Megapack energy storage plant in Shanghai, for which the US electric carmaker broke ground at the ...
Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024
KTLA-TV Los Angeles· 2 days agoShanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech developing innovative Tumor-Infiltrating Lymphocyte (TIL) therapies for cancers, announced ...
